Are the anti-cyclic citrullinated peptide antibodies independent predictors of myocardial involvement in patients with active rheumatoid arthritis?

被引:20
|
作者
Marasovic-Krstulovic, Daniela [1 ]
Martinovic-Kaliterna, Dusanka [1 ]
Fabijanic, Damir [2 ]
Morovic-Vergles, Jadranka [3 ]
机构
[1] Split Univ Hosp Ctr, Dept Rheumatol & Clin Immunol, HR-21000 Split, Croatia
[2] Split Univ Hosp Ctr, Dept Cardiol, HR-21000 Split, Croatia
[3] Dubrava Univ Hosp, Dept Rheumatol & Clin Immunol, Zagreb, Croatia
关键词
Rheumatoid arthritis; Left ventricular dysfunction; Doppler echocardiography; DIASTOLIC FUNCTION ABNORMALITIES; EVIDENT CARDIOVASCULAR-DISEASE; HEART-FAILURE; ECHOCARDIOGRAPHIC EVALUATION; VENTRICULAR-FUNCTION; TISSUE DOPPLER; RISK; AUTOANTIBODIES; MORTALITY; DURATION;
D O I
10.1093/rheumatology/ker121
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Methods. The study included 80 RA patients (70 females and 10 males) with no clinically evident CV disease, or concomitant diseases, and 80 matched healthy controls. Upon clinical and laboratory evaluation, all subjects underwent M-mode, two-dimensional and colour Doppler echocardiographic examination. Results. Isovolumetric relaxation time (IVRT) prolongation as the first sign of diastolic dysfunction was present in 36.25% of RA patients and in 15% of control subjects. IVRT was found to correlate with anti-CCP antibody titre (r = 0.382, P = 0.002) and modified DAS including CRP [DAS-28-CRP(4v)] (r = 0.204, P = 0.039). On multivariate linear regression analysis, anti-CCP antibody titre showed significant correlation with IVRT, while the ratio of early and late transmitral wave (E/A ratio) independently correlated with age and DAS-28-CRP(4v). Conclusions. Anti-CCP antibody is an important marker, independently associated with impaired left ventricular relaxation and the DAS-28-CRP(4v) is a more sensitive predictor of cardiac involvement in the RA than the DAS-28 variant including the ESR.
引用
收藏
页码:1505 / 1512
页数:8
相关论文
共 50 条
  • [31] Discriminative and diagnostic value of anti-cyclic citrullinated peptide antibodies in Iranian patients with rheumatoid arthritis
    Moghimi, Jamileh
    Ghorbani, Raheb
    Hasani, Farnaz
    Sheikhvatan, Mehrdad
    RHEUMATOLOGY INTERNATIONAL, 2013, 33 (03) : 601 - 605
  • [32] Effect of infliximab therapy on anti-cyclic citrullinated peptide antibodies levels in patients with rheumatoid arthritis
    Kyriazis, NC
    Papalopoulou, M
    Balla, M
    ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 : 172 - +
  • [33] Anti-cyclic citrullinated peptide antibodies in patients with juvenile idiopathic arthritis
    Hromadnikova, I
    Stechova, K
    Vavrincova, P
    Hridelova, D
    Houbova, B
    Voslarova, S
    Nekvasilova, H
    Vavrinec, J
    AUTOIMMUNITY, 2002, 35 (06) : 397 - 401
  • [34] Anti-cyclic citrullinated peptide antibodies in psoriasis patients without arthritis
    Böckelmann, R
    Gollnick, H
    Bonnekoh, B
    ARTHRITIS AND RHEUMATISM, 2006, 54 (05): : 1701 - 1702
  • [35] Diagnostic value of anti-cyclic citrullinated peptide antibodies in patients with rheumatoid arthritis treated with etanercept
    Drynda, S.
    Wollenberg, H.
    Khne, C.
    Polter, J.
    Kekow, J.
    ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 : A21 - A22
  • [36] THE DIAGNOSTIC UTILITY OF ANTI-MUTATED CITRULLINATED VIMENTIN ANTIBODIES, ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODIES AND RHEUMATOID FACTOR IN RHEUMATOID ARTHRITIS
    Eldin, A. Radr
    Mobasher, S. A.
    Hegazy, G.
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 898 - 898
  • [37] Diagnostic utility of anti-cyclic citrullinated peptide and anti-modified citrullinated vimentin antibodies in rheumatoid arthritis
    Keskin, Goksal
    Inal, Ali
    Keskin, Dilek
    Pekel, Aysel
    Baysal, Ozan
    Dizer, Ufuk
    Sengul, Ali
    PROTEIN AND PEPTIDE LETTERS, 2008, 15 (03): : 314 - 317
  • [38] Anti-cyclic citrullinated peptide antibodies in rheumatoid arthritis, brucellar arthritis and Behcet's disease
    Aridogan, Buket Cicioglu
    Cetin, Emel Sesli
    Yildirim, Mehmet
    Kaya, Selcuk
    Ceyhan, Ali Murat
    Demirci, Mustafa
    Savas, Serpil
    Ural, Onur
    Akkus, Selami
    AFRICAN JOURNAL OF MICROBIOLOGY RESEARCH, 2011, 5 (19): : 2975 - 2979
  • [39] Rheumatoid factor, but not anti-cyclic citrullinated peptide antibodies, is modulated by infliximab treatment in rheumatoid arthritis
    De Rycke, L
    Verhelst, X
    Kruithof, E
    Van den Bosch, F
    Hoffman, IEA
    Veys, EM
    De Keyser, F
    ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 (02) : 299 - 302
  • [40] RHEUMATOID FACTOR IGA AND ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODIES: PREDICTORS OF RADIOGRAPHIC PROGRESSION
    Dahanayake, Chanaka
    Ma, Margaret H.
    Scott, Ian C.
    Kingsley, Gabrielle H.
    Cope, Andrew
    Scott, David L.
    RHEUMATOLOGY, 2013, 52 : 69 - 69